Halozyme Therapeutics Inc. financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 05/11/2026 | Jun 2026Filed 06/08/2026 | Mar 2026Filed 11/05/2026 | Sep 2025Filed 05/11/2026 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 11/05/2026 | Sep 2024Filed 03/11/2025 | Jun 2024Filed 05/08/2025 |
|---|---|---|---|---|---|---|---|---|
| $493 | $481 | $377 | $354 | $326 | $265 | $290 | $231 | |
| $247 | $230 | $150 | $175 | $165 | $118 | $137 | $93 | |
| $2.01 | $1.90 | $1.22 | $1.43 | $1.33 | $0.93 | $1.05 | $0.72 | |
| 123 | 121 | 123 | 122 | 124 | 127 | 130 | 129 |
Trend